Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s traded shares stood at 1.34 million during the last session, with the company’s beta value hitting 1.82. At the close of trading, the stock’s price was $1.75, to imply a decrease of -2.78% or -$0.05 in intraday trading. The MIST share’s 52-week high remains $2.75, putting it -57.14% down since that peak but still an impressive 36.0% since price per share fell to its 52-week low of $1.12.
Analysts have given a consensus recommendation of Buy for Milestone Pharmaceuticals Inc (MIST), translating to a mean rating of 1.40. Of 3 analyst(s) looking at the stock, 0 analyst(s) give MIST a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.15.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
After registering a -2.78% downside in the last session, Milestone Pharmaceuticals Inc (MIST) has traded red over the past five days. The 5-day price performance for the stock is -17.84%, and -13.37% over 30 days. With these gigs, the year-to-date price performance is -25.85%.
The extremes give us $10 and $10 for target low and target high price respectively. As such, MIST has been trading -471.43% off suggested target high and -471.43% from its likely low.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
The rating firms project that company’s revenue will shrink -100.00% compared to the previous financial year.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -7.22% for the past 5-year period. While 2025 is set for a 54.82% return in earnings, projections for the next 5 years are at 26.29% annually.
MIST Dividends
Milestone Pharmaceuticals Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
The next major institution holding the largest number of shares is RTW INVESTMENTS, LP with 3.26 million shares, or about 4.9211% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $4.3 million.
We also have SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF and Fidelity NASDAQ Composite Index Fund as the top two Mutual Funds with the largest holdings of the Milestone Pharmaceuticals Inc (MIST) shares. Going by data provided on Nov 30, 2024, SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF holds roughly 19.12 shares. This is just over 0.04% of the total shares, with a market valuation of $33454.0. Data from the same date shows that the other fund manager holds a little less at 19.87, or 0.04% of the shares, all valued at about 34776.0.
